Amanda M. Esch, Ph.D.
Affiliations: | 2011 | University of Wisconsin, Madison, Madison, WI |
Area:
Transcriptional regulation in DNA tumor viruses and breast cancerGoogle:
"Amanda Esch"Mean distance: 10.32 | S | N | B | C | P |
Parents
Sign in to add mentor| Janet E. Mertz | grad student | 2011 | UW Madison | |
| (Identification of surrogate biomarkers of estrogen-related receptor alpha (ERRalpha) activity in breast cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Carvajal-Hausdorf DE, Patsenker J, Stanton KP, et al. (2019) Multiplexed Measurement of Signaling Targets and Cytotoxic T cells in Trastuzumab-treated Patients using Imaging Mass Cytometry. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Carvajal-Hausdorf D, Stanton K, Patsenker J, et al. (2018) Abstract P2-09-18: Multiplexed (18-Plex) measurement of protein targets in trastuzumab-treated patients using imaging mass cytometry Cancer Research. 78 |
| Brady SW, McQuerry JA, Qiao Y, et al. (2017) Combating subclonal evolution of resistant cancer phenotypes. Nature Communications. 8: 1231 |
| Korkola JE, Collisson EA, Heiser LM, et al. (2017) Correction: Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer. Plos One. 12: e0186551 |
| Hassan S, Esch A, Liby T, et al. (2017) Pathway-enriched gene signature associated with 53BP1 response to PARP inhibition in triple-negative breast cancer. Molecular Cancer Therapeutics |
| Hassan S, Esch A, Heiser LM, et al. (2017) Abstract B24: Genomic prediction of response to PARP inhibition in breast cancer Molecular Cancer Research. 15 |
| Villarroel-Espindola F, Carvajal-Hausdorf D, Datar I, et al. (2017) Abstract 1635: Multiplexed analysis of fixed tumor tissues using imaging mass cytometry Cancer Research. 77: 1635-1635 |
| Hu Z, Mao JH, Curtis C, et al. (2016) Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer. Breast Cancer Research : Bcr. 18: 70 |
| Esch A, Heiser L, Gray JW. (2015) Biological indicators of response and resistance to PARP inhibition in BRCA wild-type breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 125 |
| Korkola JE, Collisson EA, Heiser L, et al. (2015) Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer. Plos One. 10: e0133219 |